RENMEDA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 128,640 | 144,030 | 164,553 | 198,347 | 223,142 | 200,493 | 157,935 | 185,170 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -38,419 | -15,773 | 33,054 | 47,973 | 39,909 | 11,583 | -29,294 | -17,790 |
| Equity | 44,501 | 28,728 | 60,840 | 103,482 | 124,658 | 121,145 | 86,792 | 69,002 |
| Liabilities | 13,804 | 19,364 | 11,205 | 8,265 | 21,330 | 20,068 | 14,647 | 19,620 |
| Non-current assets | 44,671 | 37,783 | 31,083 | 36,560 | 38,508 | 30,752 | 25,164 | 24,884 |
| Current assets | 13,634 | 10,309 | 40,962 | 75,187 | 107,480 | 110,461 | 76,275 | 63,738 |
| Total assets | 58,305 | 48,092 | 72,045 | 111,747 | 145,988 | 141,213 | 101,439 | 88,622 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 19,355 | 21,883 | 16,579 |
| Social insurance contributions | - | - | - | - | - | 21,385 | 22,307 | 21,891 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -31.1% | +12.0% | +14.2% | +20.5% | +12.5% | -10.2% | -21.2% | +17.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -65.9% | -32.8% | 45.9% | 42.9% | 27.3% | 8.2% | -28.9% | -20.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -86.3% | -54.9% | 54.3% | 46.4% | 32.0% | 9.6% | -33.8% | -25.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -29.9% | -11.0% | 20.1% | 24.2% | 17.9% | 5.8% | -18.5% | -9.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.7 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 10,089 | 13,503 | 16,319 | 18,309 | 21,422 | 18,227 | 16,625 | 22,908 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
RENMEDA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-10 | 0.01 |
| 2026-07-16 | 2026-07-17 | 2046.06 |
| 2026-06-16 | 2026-06-16 | 55.57 |
| 2026-05-17 | 2026-05-17 | 2050.46 |
| 2026-03-27 | 2026-03-27 | 1941.79 |
| 2026-03-17 | 2026-03-18 | 1941.79 |
| 2025-11-26 | 2025-12-15 | 0.91 |
| 2024-11-18 | 2024-11-18 | 1868.55 |
| 2024-08-05 | 2024-08-15 | 0.01 |
| 2024-07-24 | 2024-08-04 | 5.01 |
| 2024-05-16 | 2024-05-19 | 1881.03 |
| 2024-04-23 | 2024-05-15 | 5.00 |
| 2024-04-16 | 2024-04-18 | 1910.40 |
| 2024-02-19 | 2024-02-19 | 1888.29 |
| 2024-01-23 | 2024-02-18 | 0.55 |
| 2024-01-16 | 2024-01-18 | 1803.86 |
| 2023-10-25 | 2023-11-07 | 1.21 |
| 2023-07-28 | 2023-08-15 | 2.41 |
| 2023-07-24 | 2023-07-25 | 2.50 |
| 2023-06-16 | 2023-06-18 | 1664.81 |
| 2023-05-02 | 2023-05-15 | 2.07 |
| 2023-04-26 | 2023-04-28 | 2.07 |
| 2023-02-17 | 2023-02-20 | 1723.39 |
| 2023-02-06 | 2023-02-16 | 1.60 |
| 2023-01-24 | 2023-02-03 | 1.60 |
| 2022-07-25 | 2022-08-15 | 0.18 |
| 2022-04-28 | 2022-05-15 | 1.15 |
| 2021-12-30 | 2022-01-16 | 0.02 |
| 2021-12-16 | 2021-12-29 | 0.01 |
| 2021-11-16 | 2021-11-16 | 1209.75 |
| 2021-11-05 | 2021-11-15 | 1.47 |
| 2021-09-16 | 2021-09-16 | 1278.49 |
RENMEDA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-05-08 | 2026-05-14 | 7.28 |
| 2026-03-20 | 2026-05-07 | 0.04 |
| 2026-03-08 | 2026-03-08 | 0.04 |
| 2026-03-02 | 2026-03-07 | 31.11 |
| 2026-02-27 | 2026-03-01 | 31.0 |
| 2026-02-21 | 2026-02-26 | 5.6 |
| 2026-02-12 | 2026-02-20 | 600.66 |
| 2026-01-14 | 2026-01-14 | 756.08 |
| 2025-12-12 | 2025-12-12 | 1337.85 |
| 2025-10-16 | 2025-10-18 | 1337.15 |
| 2025-09-19 | 2025-09-20 | 10.96 |
| 2025-08-19 | 2025-09-14 | 0.63 |
| 2025-08-17 | 2025-08-18 | 837.65 |
| 2025-08-16 | 2025-08-16 | 832.68 |
| 2025-08-15 | 2025-08-15 | 826.92 |
| 2025-07-16 | 2025-08-14 | 10.73 |
| 2025-06-11 | 2025-06-12 | 722.15 |
| 2025-05-19 | 2025-05-20 | 8.06 |
| 2025-05-17 | 2025-05-18 | 5.86 |
| 2025-04-16 | 2025-05-05 | 5.61 |
| 2025-02-28 | 2025-02-28 | 0.15 |
| 2025-02-25 | 2025-02-27 | 0.0 |
| 2025-02-24 | 2025-02-24 | 0.0 |
| 2025-02-23 | 2025-02-23 | 0.0 |
| 2025-02-21 | 2025-02-22 | 0.0 |
| 2025-02-20 | 2025-02-20 | 0.0 |
| 2025-02-19 | 2025-02-19 | 0.0 |
| 2025-02-18 | 2025-02-18 | 0.0 |
| 2025-02-17 | 2025-02-17 | 0.0 |
| 2025-02-16 | 2025-02-16 | 0.0 |
| 2025-02-14 | 2025-02-15 | 0.0 |
| 2025-02-13 | 2025-02-13 | 0.0 |
| 2025-02-10 | 2025-02-12 | 0.0 |
| 2025-02-09 | 2025-02-09 | 0.0 |
| 2025-02-07 | 2025-02-08 | 0.0 |
| 2025-02-06 | 2025-02-06 | 0.0 |
| 2025-02-05 | 2025-02-05 | 0.0 |
| 2025-02-04 | 2025-02-04 | 0.0 |
| 2025-02-03 | 2025-02-03 | 0.0 |
| 2025-02-02 | 2025-02-02 | 0.0 |
| 2025-02-01 | 2025-02-01 | 0.0 |
| 2025-01-30 | 2025-01-31 | 0.0 |
| 2025-01-29 | 2025-01-29 | 0.0 |
| 2025-01-28 | 2025-01-28 | 0.0 |
| 2025-01-27 | 2025-01-27 | 0.0 |
| 2025-01-26 | 2025-01-26 | 0.0 |
| 2025-01-24 | 2025-01-25 | 0.0 |
| 2025-01-23 | 2025-01-23 | 0.0 |
| 2025-01-22 | 2025-01-22 | 0.0 |
| 2025-01-15 | 2025-01-21 | 0.0 |
| 2025-01-14 | 2025-01-14 | 0.0 |
| 2025-01-13 | 2025-01-13 | 0.0 |
| 2025-01-12 | 2025-01-12 | 0.0 |
| 2025-01-10 | 2025-01-11 | 0.0 |
| 2025-01-09 | 2025-01-09 | 0.0 |
| 2025-01-01 | 2025-01-08 | 11.88 |
| 2024-12-30 | 2024-12-31 | 11.52 |
| 2024-12-29 | 2024-12-29 | 11.52 |
| 2024-12-28 | 2024-12-28 | 67.49 |
| 2024-12-27 | 2024-12-27 | 11.52 |
| 2024-12-26 | 2024-12-26 | 11.52 |
| 2024-12-25 | 2024-12-25 | 11.52 |
| 2024-12-24 | 2024-12-24 | 11.52 |
| 2024-12-23 | 2024-12-23 | 11.52 |
| 2024-12-22 | 2024-12-22 | 11.52 |
| 2024-12-20 | 2024-12-21 | 11.52 |
| 2024-12-19 | 2024-12-19 | 11.52 |
| 2024-12-18 | 2024-12-18 | 1353.26 |
| 2024-12-17 | 2024-12-17 | 1341.74 |
| 2024-12-16 | 2024-12-16 | 0.0 |
| 2024-12-15 | 2024-12-15 | 0.0 |
| 2024-12-13 | 2024-12-14 | 0.0 |
| 2024-12-12 | 2024-12-12 | 0.0 |
| 2024-12-11 | 2024-12-11 | 0.0 |
| 2024-12-10 | 2024-12-10 | 0.0 |
| 2024-12-08 | 2024-12-09 | 0.0 |
| 2024-12-06 | 2024-12-07 | 0.0 |
| 2024-12-05 | 2024-12-05 | 0.0 |
| 2024-12-04 | 2024-12-04 | 0.0 |
| 2024-12-03 | 2024-12-03 | 0.0 |
| 2024-12-01 | 2024-12-02 | 0.0 |
| 2024-11-29 | 2024-11-30 | 0.0 |
| 2024-11-28 | 2024-11-28 | 0.0 |
| 2024-11-27 | 2024-11-27 | 0.0 |
| 2024-11-26 | 2024-11-26 | 0.0 |
| 2024-11-25 | 2024-11-25 | 0.0 |
| 2024-11-24 | 2024-11-24 | 0.0 |
| 2024-11-22 | 2024-11-23 | 0.0 |
| 2024-11-20 | 2024-11-21 | 11.58 |
| 2024-11-18 | 2024-11-19 | 11.58 |
| 2024-11-17 | 2024-11-17 | 11.58 |
| 2024-10-16 | 2024-11-16 | 1379.74 |
| 2024-10-14 | 2024-10-15 | 0.0 |
| 2024-10-10 | 2024-10-13 | 0.0 |
| 2024-10-09 | 2024-10-09 | 0.0 |
| 2024-10-07 | 2024-10-08 | 0.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
RENMEDA, UAB (code 300927708) is a Private Limited Liability Company engaged in medical specialists activities. In the latest financial year, 2025, the company generated revenue of €185.2K, up 17.2% year on year after €157.9K in 2024, but still below the €200.5K achieved in 2023. Net profit remained negative at €17.8K in 2025, improving from a loss of €29.3K in 2024, while 2023 closed with a profit of €11.6K. The profit margin was -9.6% in 2025, compared with -18.5% in 2024 and 5.8% in 2023, showing a partial recovery but continued pressure on profitability. Balance sheet size decreased over the period: total assets were €88.6K in 2025, down from €101.4K in 2024 and €141.2K in 2023. Equity declined to €69.0K, while liabilities were €19.6K, resulting in an equity ratio of 77.9% and debt to equity of 0.28. Asset turnover reached 2.09x, with ROE at -25.8% and ROA at -20.1%. Revenue per employee was €23.1K, and profit per employee was -€2.2K.